Sartorius Stedim Biotech S.A.
General ticker "SDMHF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $21.2B (TTM average)
Sartorius Stedim Biotech S.A. does not follow the US Stock Market performance with the rate: -0.0%.
Estimated limits based on current volatility of 1.4%: low 200.67$, high 206.17$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-01, amount 0.80$ (Y0.39%)
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [185.69$, 279.65$]
- 2026-12-31 to 2027-12-31 estimated range: [181.80$, 276.21$]
Financial Metrics affecting the SDMHF estimates:
- Negative: with PPE of 61.3 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 18.50 > 18.39
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 3.21
- Positive: 42.59 < Shareholder equity ratio, % of 51.02 <= 64.29
- Negative: Investing cash flow per share per price, % of -1.96 <= -0.60
- Positive: -0.02 < Operating cash flow per share per price, % of 2.65
Short-term SDMHF quotes
Long-term SDMHF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €2,775.50MM | €2,780.00MM | €2,966.39MM |
| Operating Expenses | €2,326.00MM | €2,409.40MM | €2,417.59MM |
| Operating Income | €449.50MM | €370.60MM | €548.79MM |
| Non-Operating Income | €-48.40MM | €-151.40MM | €-175.73MM |
| Interest Expense | €117.00MM | €164.50MM | €152.64MM |
| R&D Expense | €153.10MM | €144.10MM | €0.00MM |
| Income(Loss) | €401.10MM | €219.20MM | €373.06MM |
| Taxes | €89.00MM | €40.70MM | €107.26MM |
| Net Income(Loss)* | €309.70MM | €175.10MM | €265.50MM |
| Stockholders Equity | €2,637.90MM | €3,986.60MM | €4,088.97MM |
| Inventory | €882.40MM | €684.90MM | €690.64MM |
| Assets | €7,739.90MM | €8,256.40MM | €8,014.40MM |
| Operating Cash Flow | €746.40MM | €815.10MM | €538.40MM |
| Capital expenditure | €473.60MM | €339.80MM | €393.05MM |
| Investing Cash Flow | €-2,722.70MM | €-340.00MM | €-397.55MM |
| Financing Cash Flow | €1,986.10MM | €84.90MM | €-389.05MM |
| Earnings Per Share** | €3.36 | €1.81 | €2.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.